KGA-4066
KGA-4066 is an innovative non-ATP competitive CDK2 inhibitor. It suppresses CDK2/Cyclin A2 with an IC50 value of 236.7 nM, disrupts their interaction, and promotes CDK2 degradation via the lysosomal pathway. KGA-4066 exhibits anticancer activity against hepatocellular carcinoma.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E45H03474-2 20 µg
SLC30A2 (NM_001004434) Human Over-expression Lysate
Sign In for Pricing
View Details